| Literature DB >> 36117796 |
Abdulrahman Alsunbul1, Hamad Alakrash1, Muaiqel AlMuaiqel1, Abdullah W Aldughiman1, Abdulaziz Albalawi1, Abdullah S Al-Gadheeb1, Hossam S El-Tholoth1, Tarek Alzahrani1, Ahmed Alzahrani1.
Abstract
Objective: The objective of the study is to evaluate the safety, efficacy, and long-term outcome of en bloc renal pedicle control during laparoscopic nephrectomy and nephroureterectomy. Patients andEntities:
Keywords: Arteriovenous fistula; laparoscopy; nephrectomy; nephroureterectomy
Year: 2022 PMID: 36117796 PMCID: PMC9472313 DOI: 10.4103/UA.UA_182_20
Source DB: PubMed Journal: Urol Ann ISSN: 0974-7796
Figure 1(a) A lower window creation. The ureter is lifted with the nondominant hand, and the psoas muscle is clearly visible after clearing the inferior border of the kidney. (b) Upper window creation; the adrenal gland is spared if there is to be adrenalectomy (blue mark). (c) After completion, the psoas muscle should be visible before any attempt at applying an endovascular stapler device
Figure 2(a) The view of an upper and lower window (indicated by blue and green, respectively) before applying the endovascular stapler device. (b) The endovascular device is introduced through the lower quadrant port going from the lower window to the upper window. It is essential to ensure that the lower jaw of the device is seen through the upper pole of the kidney prior to any attempt at using the instrument
Patient demographics and preoperative findings
| Parameter | Mean (% or range) |
|---|---|
| Age (years) | 55.7 (18-94) |
| BMI (kg/m2) | 29.2 (17-42) |
| Male ( | 74 (58.7%) |
| Female ( | 52 (41.3) |
| Side ( | |
| Left | 79 (62.7%) |
| Right | 47 (37.3%) |
| Indication of nephrectomy ( | |
| Nonfunctioning kidney | 55 (43.7%) |
| Renal tumors | 66 (52.3%) |
| Low score 4-6 | 2 (3%) |
| Moderate score 7-9 | 33 (50%) |
| High score 10-12 | 31 (46.96%. almost 47%) |
| Ureteric or renal-pelvic tumors | 5 (3.97%) |
| Multiple arteries | 6 (4.8%) |
| Multiple veins | 6 (4.8%) |
BMI: Body mass index
Intra and postoperative findings
| Parameter | Mean (% or range) |
|---|---|
| Estimated blood loss (ml) | 75 (20-200) |
| Intraoperative transfusion rates ( | 2 (1.5%) |
| Conversion to open surgery ( | 2 (1.6%) |
| Hemostatic agent used | 66 (52.4%) |
| Intraoperative complications ( | 3 (2.4%) |
| Operative time (min) | 91.8 (45-215) |
| Postoperative complications ( | 3 (2.4%) |
| Hospital stay (days) | 5 (3-10) |
Follow-up findings
| Parameter | Mean (% or range) |
|---|---|
| Mean duration of follow-up (months) | 23.3 (12-48) |
| Imaging used for follow-up | |
| Ultrasound Doppler | 35 (27.8%) |
| CT with contrast | 61 (48.4%) |
| MRI | 30 (23.8%) |
| Symptoms or signs of AVF ( | 0 |
| Imaging finding suggest AVF ( | 0 |
AVF: Arteriovenous fistula, CT: Computed tomography, MRI: Magnetic resonance imaging